156. We never thought China’s ambition was to be like America tomorrow

Simon Edelsten and Alex Illingworth, managers of the Mid Wynd International Investment Trust, tell us why governance issues played a key role in their decision to sell all of their holdings in China. The pair also discuss the role of healthcare and automation as key themes in their portfolio and why they hold Pfizer despite being averse to large pharmaceutical companies. The managers also tell us why the best returns from wind farms, as a low carbon theme, are behind us.
Apple Podcast Spotify Podcast

The Mid Wynd International Investment Trust looks to grow real wealth by investing in a portfolio of high-quality, global equities. Managed by Simon Edelsten and Alex Illingworth, the trust invests across numerous themes, such as automation; online services; scientific equipment; healthcare costs; and Fintech, with each one not only having a promising five-year growth trajectory but also including some of the best quality growth companies available. Investments are made if the team believes the market is not recognising the long-term growth potential of a stock, with the final portfolio consisting of between 55-70 companies.

Read more about Mid Wynd International Investment Trust

What’s covered in this podcast:

  • How changing trends in society help the managers spot long-term growth industries they want to invest in [0:16]
  • How the team review these themes and adjust if the world around them changes [1:52]
  • The role of automation in both worker and energy efficiency [3:26]
  • Why managed care companies are the gatekeepers when it comes to reducing costs in healthcare [5:09]
  • Why scientific testing companies are playing a much bigger role in healthcare than they ever have before [6:30]
  • Why they are happy to invest in Pfizer but avoid other large pharmaceutical companies [7:32]
  • The managers explain which warning signs were a catalyst for them to start selling all their holdings in China [10:50]
  • Finding new opportunities in the ESG space [13:38]
  • Simon tell us why the best returns from wind farms have already been made [15:25]
This article is provided for information only. The views of the author and any people quoted are their own and do not constitute financial advice. The content is not intended to be a personal recommendation to buy or sell any fund or trust, or to adopt a particular investment strategy. However, the knowledge that professional analysts have analysed a fund or trust in depth before assigning them a rating can be a valuable additional filter for anyone looking to make their own decisions. Past performance is not a reliable guide to future returns. Market and exchange-rate movements may cause the value of investments to go down as well as up. Yields will fluctuate and so income from investments is variable and not guaranteed. You may not get back the amount originally invested. Tax treatment depends of your individual circumstances and may be subject to change in the future. If you are unsure about the suitability of any investment you should seek professional advice. Whilst FundCalibre provides product information, guidance and fund research we cannot know which of these products or funds, if any, are suitable for your particular circumstances and must leave that judgement to you. Before you make any investment decision, make sure you’re comfortable and fully understand the risks. Further information can be found on Elite Rated funds by simply clicking on the name highlighted in the article.